Drug intelligence / Profile preview

human umbilical cord tissue-derived mesenchymal stem cells

Development stage: Discontinued
Lead developer: Translational Biosciences
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intraarticular

Overview

Human umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) are an allogeneic cell therapy being developed by Translational Biosciences for the treatment of osteoarthritis, specifically targeting the knee. These cells are isolated from the umbilical cord tissue and are known for their multipotency and significant immunomodulatory and anti-inflammatory properties. When administered intravenously or intra-articularly, UC-MSCs are thought to migrate to the site of joint damage and release a variety of bioactive molecules, including cytokines and growth factors, which help to reduce synovial inflammation and potentially stimulate the repair of damaged cartilage. This therapeutic approach aims to provide a safe and effective treatment option for patients suffering from the pain and functional limitations associated with osteoarthritis.

Other names: Umbilical Cord Tissue Mesenchymal Stem CellsAllogeneic human umbilical cord tissue-derived stem cells

Beyond the preview

Go deeper on human umbilical cord tissue-derived mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on human umbilical cord tissue-derived mesenchymal stem cells.

Explore the full profile